azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['bet', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
#ash22 #leusm daver: orr with pivek/aza/ven better in ven naive, orr 53%, 26% cr, best in 1st relapse with 41% cr. good responses in idh2m. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)